Supporting the

Neuroendocrine Cancer Community

The Big Cancer52 Conversation

The Big Cancer52 Conversation

The Big Cancer52 Conversation on Wednesday 14th June brought together leaders from the charity, healthcare and pharmaceutical sectors, to share best practices, exchange ideas and explore collaborations, with the ultimate aim of improving outcomes for people with rare...
CANCER 52 All Member Meeting 12th October 2022

CANCER 52 All Member Meeting 12th October 2022

CANCER52 All Member Meeting Follow for coverage of the Day -12th Oct 2022 Cancer52 have launched their report – Taking Action on Inequalities in Rare and Less Common Cancers: Understanding the Issues – at their Annual All Stakeholder Event, which also focused on...
Cancer52 Showcase Video response to the Covid-19 pandemic

Cancer52 Showcase Video response to the Covid-19 pandemic

Delighted to launch the Cancer52 video showcasing the amazing work of Cancer52 members in response to the Covid-19 pandemic. The Showcase Video highlights the innovation and tenacity of our members in the face of the extraordinary challenges of the past couple of...
Cancer52 CEO Meeting

Cancer52 CEO Meeting

Always a pleasure to attend the Cancer 52 CEO meetings, where there is an opportunity to discuss common issues and ways in which we can support each others organisations, despite the difference of focus in terms of disease area. This week’s meeting was mainly...